• Chlordiazepoxide, Serum
  • Mycoplasma pneumoniae Antibody, IgA
  • Cortisol, Salivary
  • Biopsy, Liver
  • Zolpidem, Serum
  • HER2/neu (ERBB2) Gene Amplification, FISH, Urothelial Carcinoma
  • BCR-ABL Translocation by RT-PCR, Quantitative, Bone Marrow
  • Ammonia, Urine
  • Biopsy, Thymus
  • Gene Expression Profile for Cutaneous Melanoma, DermTech (DecisionDx®-SCC), Pigmented Lesion Assay (PLA), myPath® Melanoma, Merlin™ Test
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prosigna Breast Cancer Prognostic Gene Signature
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

ICD10
Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.
Loading...